◦
Mp: 74.5–75.6 C; [a]2D0 (c 1.2, CH2Cl2) +121.6; 1H NMR
[a]2D0 (c 0.90, CH2Cl2)–10.3; 1H NMR (400 MHz, CDCl3, d ppm)
d 7.60 (d, 1H; J = 8.3 Hz), 7.50 (t, 1H; J = 7.8 Hz), 6.80 (d, 1H;
J = 7.3 Hz), 4.34 (dd, 1H; J = 8.1 Hz, 8.9 Hz), 4.09 (dd, 1H; J =
6.9 Hz, 8.0 Hz), 3.7 (td, 1H; J = 6.5 Hz, J = 8.9 Hz), 3.54 (s,
3H), 2.49 (s, 3H), 1.02 (d, 3H, J = 6.7 Hz), 0.93 (d, 3H, J = 6.7);
13C NMR (100 MHz, CDCl3, d ppm) d 156.3, 154.5, 137.2, 117.2,
113.7, 70.5, 70.4, 35.2, 33.3, 24.4, 18.9, 17.9; m/z (ESI+) 234; IR
(cm-1): 1648. Anal. Calcd. for C13H19N3O: C, 66.9; H, 8.1; N, 22.8.
Found: C, 65.7; H, 7.7; N, 21.2.
(400 MHz, CDCl3, d ppm) d 7.45 (t, 1H; J = 7.7 Hz), 6.83 (d, 1H;
J = 8.1 Hz), 6.69 (d, 1H; J = 7.3 Hz), 4.34 (t, 1H; J = 8.8 Hz), 4.20
(dd, 1H; J = 5.4 Hz, 8.9 Hz), 3.8 (dd, 1H; J = 5.4 Hz, J = 8.7 Hz),
2.44 (s, 3H), 0.95 (s, 9H); 13C NMR (100 MHz, CDCl3, d ppm) d
153.6, 137.0, 122.4,120.6, 114.9, 64.9, 44.5, 32.7, 30.0, 24.1, 23.5
m/z (ESI+) 234; IR (cm-1): 1644. Anal. Calcd. for C12H17ON3:
C,66.95; H,8.15; N,18.03. Found: C, 57.23; H, 8.8; N, 12.78.
General procedure for the methylation of aza-pyridinoxazolines
(S)-4-tert-butyl-N-methyl-N-(6-methylpyridin-2-yl)-4,5-
The corresponding aza-pyridinoxazoline (1 mmol) was dissolved
in THF (10 ml) and a 15% solution of n-butyl lithium in hexane
(1.5 N, 688 mL) was added at -78 ◦C. After stirring for 20 min
iodomethane (2.5 mmol, 355 mg) was added. The cooling bath
was removed and stirring at room temperature continued for
10 h. After evaporation of the solvent the residue was partitioned
between CH2Cl2 (10 ml) and saturated NaHCO3 (10 ml). The
aqueous phase was extracted with CH2Cl2 (2 ¥ 5 ml) and the com-
bined organic phases dried over NaSO4. Evaporation of the solvent
yielded the corresponding products as yellow oils.
dihydrooxazol-2-amine (10d)
Prepared according to the general procedure using 220 mg of 9d
to yield 98%.
[a]2D0 (c 0.90, CH2Cl2) +15.1; H NMR (400 MHz, CDCl3, d
1
ppm) d 7.61 (t, 1H; J = 8.3 Hz), 7.47 (dd, 1H; J = 7.4 Hz, 8.3 Hz),
6.76 (d, 1H; J = 7.3 Hz), 4.25 (dd, 1H; J = 8.5 Hz, 9.2 Hz), 4.17
(dd, 1H; J = 6.4 Hz, 8.4 Hz), 3.86 (dd, 1H; J = 6.4 Hz, J = 9.3 Hz),
3.5 (s, 3H), 2.5 (s, 3H), 0.91 (s, 9H); 13C NMR (100 MHz, CDCl3,
d ppm) d 156.3, 154.5, 137.2, 117.1, 113.5, 74.1, 68.9, 35.1, 34.1,
30.9, 25.7, 24.4 m/z (ESI+) 248; IR (cm-1): 1654. Anal. Calcd. for
C14H21N3O: C, 71.8; H, 7.8; N,14.8. Found: C, 72.4; H, 7.5; N,
15.7.
(S)-4-isopropyl-N-methyl-N-(pyridin-2-yl)-4,5-dihydrooxazol-2-
amine (10a)
Prepared according to the general procedure using 220 mg of 9a
(S)-N,N-(1,4-phenylenebis(methylene))bis(4-tert-butyl-N-
(6-methyl-pyridin-2-yl)-4,5-dihydrooxazol-2-amine (13)
to yield 98%.
1
[a]2D0 (c 0.81, CH2Cl2); -19.4; H NMR (400 MHz, CDCl3, d
248 mg (1 mmol) of 9d was dissolved in tetrahydrofuran (10 ml)
and a 15% solution of n-butyl lithium in hexane (1.5 N,
688 mL) was added at -78 ◦C. After stirring for 20 min a,a¢-
Dibromo-p-xylene (0.45 mmol, 11.88 mg) was added. The cooling
bath was removed and stirring at room temperature continued
for 10 h. After evaporation of the solvent the residue was
partitioned between CH2Cl2 (10 ml) and saturated NaHCO3
(10 ml). The aqueous phase was extracted with CH2Cl2 (2 ¥
5 ml) and the combined organic phases dried over Na2SO4.
After evaporation of the solvent, the product was purified by
chromatography on neutral alumina using ethyl acetate–hexane
7/3 and 5% Et3N as eluent to yield 70% of 13 as a yellow
oil.
ppm) d 8.26 (ddd, 1H; J = 0.8 Hz, J = 1.9 Hz, J = 4.9 Hz), 7.8
(dt, 1H; J = 0.8 Hz, 8.5 Hz), 7.52 (ddd, 1H; J = 1.9 Hz, J =
6.9 Hz, J = 7.20 Hz), 6.84 (ddd, 1H; J = 0.9 Hz, J = 4.9 Hz, J =
7.2 Hz), 4.28 (dd, 1H; J = 8.2 Hz, J = 8.9 Hz), 4.01 (dd, 1H; J =
7 Hz, 8 Hz), 3.76 (td, 1H; J = 6.7 Hz, J = 9 Hz), 3.45 (s, 3H),
1.7 (m, 1H), 0.94 (d, 3H; J = 6.7 Hz), 0.85 (d, 3H; J = 6.7 Hz);
13C NMR (100 MHz, CDCl3, d ppm) d 147.3, 136.9, 124.9, 117.9,
116.9,70.7, 70.5, 33.3, 19.0, 18.0, 16.3; m/z (ESI+) 220; IR (cm-1):
1650 Anal. Calcd. for C12H17N3O: C, 65.7; H, 7.8; N, 19.2. Found:
C, 63.7; H, 7.5; N, 17.3.
(S)-4-tert-butyl-N-methyl-N-(pyridin-2-yl)-4,5-dihydrooxazol-2-
amine (10b)
1
[a]2D0 (c 0.99, CH2Cl2) +12.3; H NMR (400 MHz, CDCl3, d
Prepared according to the general procedure using 220 mg of 9b
ppm) d 7.67 (d, 1H; J = 8.3 Hz), 7.47 (dd, 1H; J = 7.4 Hz,
8.3 Hz), 6.75 (d, 1H; J = 7.3 Hz), 5.3 (q, 2H; J = 15.1 Hz),
4.15 (m, 2H), 3.84 (dd, 1H; J = 6.2 Hz, 9.3 Hz), 2.42 (s, 3H),
0.85 (s, 9H); 13C NMR (100 MHz, CDCl3, d ppm) d 158.6, 156.2,
153.6, 137.6, 137.3, 127.5, 117.2, 113.7, 74.2, 68.7, 49.9, 34.1, 30.9,
29.7, 25.6, 24.3; m/z (ESI+) 569; IR (cm-1): 1649 Anal. Calcd.
for C34H44N6O2: C, 71.8; H, 7.8; N,14.8. Found: C, 73.7; H, 6.7;
N,15.3.
to yield 98%.
1
[a]2D0 (c 1.05, CH2Cl2) +12.5; H NMR (400 MHz, CDCl3, d
ppm) d 8.3 (ddd, 1H; J = 0.76 Hz, J = 1.91 Hz, J = 4.89 Hz), 7.9
(d, 1H; J = 8.54 Hz), 7.5 (dd, 1H; J = 1.98 Hz, J = 7.18 Hz), 6.8
(ddd, 1H; J = 0.87 Hz, 4.92 Hz, J = 7.20 Hz), 4.2 (dd, 1H; J =
8.49 Hz, J = 9.30 Hz), 4.1 (dd, 1H; J = 6.54 Hz, 8.39 Hz), 3.78
(dd, 1H; J = 6.5 Hz, J = 9.4 Hz), 3.5 (s, 3H) 0.86 (s, 9H);(hacer);
13C NMR (400 MHz, CDCl3, d ppm) d 146.0, 137.5, 120.5, 116.5,
66.0, 64.2, 50.3, 35.1, 33.7, 25.1; m/z (ESI+) 234; IR (cm-1): 1653.
Anal. Calcd. for C13H19ON3: C,66.9; H,8.2; N, 18.0. Found: C,67.3;
H,7.9; N,17.6.
Preparation of immobilized catalysts
The complex for cationic exchange was prepared by mixing
Cu(OTf)2 (65.1 mg, 0.18 mmol) with a solution of the corre-
sponding 10 ligand (0.20 mmol) in dichloromethane (2 ml). After
stirring for 30 min under an inert atmosphere, the solution was
filtered through a syringe PTFE microfilter, and the solvent was
evaporated under reduced pressure. The residue was redissolved in
anhydrous methanol (3 ml), and dried laponite (500 mg) was added
(S)-4-isopropyl-N-methyl-N-(6-methylpyridin-2-yl)-4,5-
dihydrooxazol-2-amine (10c)
Prepared according to the general procedure using 220 mg of 9c
to yield 99%.
This journal is
The Royal Society of Chemistry 2010
Dalton Trans., 2010, 39, 2098–2107 | 2105
©